Preliminary experiments reveal conolidine could inhibit specific ion channels, reducing neuronal excitability and limiting pain alerts. This mechanism is particularly appropriate in neuropathic ache, wherever irregular signaling results in persistent pain. Moreover, conolidine seems to affect G protein-coupled receptor (GPCR) pathways integral to p